inviCRO
- Company typePrivate
- Founded2008
- HeadquartersBoston, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
inviCRO firmographics
Firmographics- Name
- inviCRO
- Legal name
- Perceptive
- Website
- https://invicro.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
inviCRO industry classification
Industry- Product category
- Clinical Trial Imaging and RTSM Services
- NAICS
- Medical and Diagnostic Laboratories (62151), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Other Scientific and Technical Consulting Services (541690), Diagnostic Imaging Centers (621512)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)
Keywords
Where inviCRO is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
inviCRO business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Clinical Imaging Services: Fee-for-service clinical imaging core lab services for pharmaceutical and biotech companies conducting clinical trials. Services include imaging modality selection, protocol development, site training, image acquisition quality control, and centralized reading services.
- IRT/RTSM Services: Interactive Response Technology and Randomization Trial Supply Management services provided on a per-trial or subscription basis for managing clinical trial logistics.
- Preclinical Imaging Services: Preclinical imaging services and software licensing for early-stage drug development studies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on study requirements |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
inviCRO product offering
Product offeringCore offering
inviCRO provides full-service tissue-to-human imaging, analysis, and data management services for bio-pharmaceutical companies, spanning preclinical imaging studies, clinical trial imaging core lab operations, IRT/RTSM solutions for randomization and trial supply management, and proprietary analytical software such as VivoQuant™. The offering covers imaging modalities including PET, MRI, SPECT, CT, and optical, with radiochemistry, biodistribution, and radioligand binding assay capabilities, and is delivered through company-owned clinical and imaging centers.
Differentiator
Problem solved
Functional benefit
Products and services
- Imaging Core Lab Centralized imaging core laboratory services for clinical trials, including imaging modality selection, protocol development, site training, image acquisition quality control, and centralized reading for bio-pharmaceutical sponsors.
- Preclinical Imaging Preclinical imaging capabilities for early-stage drug development, including preclinical oncology, preclinical radioligand therapy, and preclinical and translational CNS imaging.
- IRT/RTSM Interactive Response Technology and Randomization and Trial Supply Management solutions for managing patient randomization and investigational product supply in clinical trials, offered per trial or on a subscription basis.
- VivoQuant™ Proprietary preclinical imaging analysis software for quantitative analysis of PET, SPECT, CT, and optical imaging data from preclinical studies.
- eCOA Electronic Clinical Outcome Assessment (eCOA) solution listed as a stand-alone service offering on the company's eClinical service line.
- Clinical Intelligence Clinical Intelligence analytics offering listed as part of the company's eClinical / clinical operations portfolio.
- In-House Clinical and Imaging Centers Company-owned clinical and imaging centers used to conduct first-in-human and early-phase clinical trials for bio-pharmaceutical sponsors.
- Radiochemistry Radiochemistry service for developing and producing radiopharmaceuticals used in clinical trial imaging studies.
- Biodistribution Services Biodistribution services supporting preclinical and translational imaging studies for bio-pharmaceutical sponsors.
- Radioligand Binding Assay Services Radioligand binding assay services offered as a stand-alone laboratory service line supporting radiopharmaceutical and CNS drug development.
Quantifiable outcome
- 800+ regulatory approvals supported
- +3 more outcomes
Companies that use inviCRO
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
inviCRO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
inviCRO partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
inviCRO competitors and assessment
Company assessmentDirect peers
- Clario: Clario (formed from the merger of Bioclinica and ERT) is a direct competitor offering imaging core lab services alongside eClinical solutions (EDC, eCOA, RTSM/IRT) for clinical trials. Overlap with Perceptive spans both the imaging core lab and the eClinical/RTSM service lines, making it the closest one-stop-shop peer.
- Median Technologies: Median Technologies provides imaging core lab and imaging AI solutions for oncology clinical trials, with a strong focus on tumor response assessment. Directly competes with Perceptive's oncology imaging practice for biopharma oncology trials.
- Imaging Endpoints: Imaging Endpoints is a specialized imaging core lab focused on oncology and CNS clinical trials with proprietary review workflows. Directly comparable as a specialized imaging CRO serving similar pharma and biotech customers in Perceptive's core therapeutic areas.
- Calyx: Calyx is an eClinical and imaging services provider offering RTSM/IRT, EDC, eCOA, and imaging solutions to biopharma. Direct competitor across the RTSM and clinical trial informatics service lines that Perceptive offers via its eClinical division.
Broad incumbents
- IQVIA: IQVIA is the largest global CRO with broad clinical trial services and dedicated imaging and eClinical capabilities. It competes for the same enterprise pharma clients on bundled trial outsourcing, and represents the largest bundling threat to standalone imaging CROs like Perceptive.
- ICON plc: ICON plc is a top global CRO with significant imaging, eClinical, and laboratory services post its PRA Health Sciences acquisition. It competes for end-to-end trial outsourcing deals and offers imaging capabilities that overlap with Perceptive's core lab offerings.
- Laboratory Corporation of America (LabCorp / Covance): LabCorp's Covance drug development segment is a major full-service CRO offering clinical trial imaging, central lab, and eClinical services. It competes with Perceptive across imaging core lab and end-to-end clinical trial delivery to large pharma sponsors.
- Parexel International: Parexel is a global CRO with biopharmaceutical services including clinical trial imaging and RTSM capabilities. Competes for the same late-phase enterprise pharma trials and uses bundling as a lever against specialized imaging providers.
- Charles River Laboratories: Charles River provides preclinical imaging services alongside broader CRO and research models offerings. Overlaps with Perceptive's preclinical imaging, VivoQuant-anchored early-phase work, and translational science services for biopharma clients.
- Medpace: Medpace is a mid-to-large CRO with strong therapeutic specialization in oncology, CNS, and metabolic disease — areas where Perceptive is also active. Competes for the same mid-size biotech sponsors that Perceptive targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
inviCRO social profiles
Digital presenceinviCRO financial estimates
Financial estimateRevenue estimate
Valuation estimate
inviCRO leadership team
Management profileNumber of profiles
Profiles4 records
inviCRO funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
inviCRO M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about inviCRO
What does inviCRO do?
inviCRO provides full-service tissue-to-human imaging, analysis, and data management services for bio-pharmaceutical companies, spanning preclinical imaging studies, clinical trial imaging core lab operations, IRT/RTSM solutions for randomization and trial supply management, and proprietary analytical software such as VivoQuant™. The offering covers imaging modalities including PET, MRI, SPECT, CT, and optical, with radiochemistry, biodistribution, and radioligand binding assay capabilities, and is delivered through company-owned clinical and imaging centers.
Is inviCRO a public or private company?
inviCRO is a private company. It is classified as unknown and is currently operating.
When was inviCRO founded?
inviCRO was founded in 2008. It employs 101 to 250 people.
Where is inviCRO based?
inviCRO is headquartered in Boston, United States, in the North America region.
How does inviCRO make money?
Three revenue lines are on record. Clinical Imaging Services are the primary driver. The others are IRT/RTSM Services and preclinical Imaging Services.
Who are inviCRO's main competitors?
Direct peers on record are Clario, Median Technologies, Imaging Endpoints and Calyx. Broad incumbents are IQVIA, ICON plc, Laboratory Corporation of America (LabCorp / Covance), Parexel International, Charles River Laboratories and Medpace.
Does inviCRO have an API?
No public API is recorded for inviCRO.
What industry is inviCRO in?
inviCRO's product category is Clinical Trial Imaging and RTSM Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments. Its NAICS code is 62151 and its SIC code is 8071.